SK pharmteco reaffirms its three business unit strategy - small molecules, peptides, and viral vectors - with $100 million funding commitment....
RANCHO CORDOVA, Calif., March 19, 2026 (GLOBE NEWSWIRE) -- SK pharmteco today announced a significant funding commitment to support strategic initiatives within its viral vector business, while reaff… [+2966 chars]





